Latham & Watkins advises Zentalis in exclusive license of ROR1 ADC and technology platform to Immunome

The Sponsor

Loading page...

Latham & Watkins advises Zentalis in exclusive license of ROR1 ADC and technology platform to Immunome | The Sponsor - The Sponsor